[1] BECHMANN L P, HANNIVOORT R A, GERKEN G , et al. The Interaction of hepatic lipid and glucose metabolism in liver diseases[J]. Journal of Hepatology, 2012, 56(4): 952-64. [2] FANG M, YAO M, YANG J, et al. Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis[J]. World Journal of Gastrointestinal Oncology, 2020, 12(1): 66-76. [3] LOOMBA R, SANYAL A J. The global NAFLD epidemic[J]. Nature Reviews Gastroenterology & Hepatology, 2013, 10(11): 686-90. [4] ANGULO P. Nonalcoholic fatty liver disease[J]. The New England Journal of Medicine, 2002, 346(16): 1221-1231. [5] ARAUJO A R, ROSSO N, BEDOGNI G, et al. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: what we need in the future[J]. Liver International, 2018, 38: 47-51. [6] WANG L, XU M, JONES O D, et al. Nonalcoholic fatty liver disease experiences accumulation of hepatic liquid crystal associated with increasing lipophagy[J]. Cell & Bioscience, 2020, 10: 55. [7] MALHI H, KAUFMAN R J. Endoplasmic reticulum stress in liver disease[J]. Journal of Hepatology, 2011, 54(4): 795-809. [8] ALVES-BEZERRA M, COHEN D E. Triglyceride metabolism in the liver[J]. Comprehensive Physiology, 2017, 8(1): 1-8. [9] WARDANI H A, RAHMADI M, ARDIANTO C, et al. Development of nonalcoholic fatty liver disease model by high-fat diet in rats[J]. Journal of Basic and Clinical Physiology and Pharmacology, 2019, 30(6): 73-84. [10] INRAHIM S H, HIRSOVA P, MALHI H, et al. Animal models of nonalcoholic steatohepatitis: eat, delete, and inflame[J]. Digestive Diseases and Sciences, 2016, 61(5): 1325-1336. [11] 史晓萍, 宗阿南, 陶钧, 等. 《关于善待实验动物的指导性意见》的研究[J]. 中国医科大学学报,2007(4): 131. [12] ELENA D, ELEONORA C, ANGELA M , et al. Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice[J]. Redox Biology,2018,18: 16-24. [13] DEMINICE R, DA SILVA R P, LAMARRE S G, et al. Betaine supplementation prevents fatty liver induced by a high-fat diet: effects on one-carbon metabolism[J]. Amino Acids, 2015, 47(4): 839-846. [14] JUNG C H, CHO I, AHN J, et al. Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes[J]. Phytotherapy Research, 2013, 27(1): 139-143. [15] WANG Y, ZIOGAS D C, BIDDINGER S, et al. You deserve what you eat: lessons learned from the study of the melanin-concentrating hormone (MCH)-deficient mice[J]. Gut, 2010, 59(12): 1625-1634. [16] SCHNABL B, PURBECK C A, CHOI Y H, et al. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype[J]. Hepatology, 2003, 37(3): 653-664. [17] DICKSON M A. Molecular pathways: CDK4 inhibitors for cancer therapy[J]. Clinical Cancer Research, 2014, 20(13): 3379-3383. [18] BEDOSSA P. Liver fibrosis in hepatitis B: a dynamic process[J]. Gastroenterologie Clinique et Biologique, 2010, 34: S103-S108. [19] SALMINEN A, KAUPPINEN A, KAARNIRANTA K. Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP)[J]. Cell Signaling, 2012, 24(4): 835-845.